466 related articles for article (PubMed ID: 17200375)
21. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
[TBL] [Abstract][Full Text] [Related]
22. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
23. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.
Bertario L; Russo A; Sala P; Varesco L; Giarola M; Mondini P; Pierotti M; Spinelli P; Radice P;
J Clin Oncol; 2003 May; 21(9):1698-707. PubMed ID: 12721244
[TBL] [Abstract][Full Text] [Related]
24. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH.
Chow E; Lipton L; Lynch E; D'Souza R; Aragona C; Hodgkin L; Brown G; Winship I; Barker M; Buchanan D; Cowie S; Nasioulas S; du Sart D; Young J; Leggett B; Jass J; Macrae F
Gastroenterology; 2006 Jul; 131(1):30-9. PubMed ID: 16831587
[TBL] [Abstract][Full Text] [Related]
25. The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations.
Durno CA; Holter S; Sherman PM; Gallinger S
Am J Gastroenterol; 2010 Nov; 105(11):2449-56. PubMed ID: 20531397
[TBL] [Abstract][Full Text] [Related]
26. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.
De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P
Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422
[TBL] [Abstract][Full Text] [Related]
27. The molecular basis of Turcot's syndrome.
Hamilton SR; Liu B; Parsons RE; Papadopoulos N; Jen J; Powell SM; Krush AJ; Berk T; Cohen Z; Tetu B
N Engl J Med; 1995 Mar; 332(13):839-47. PubMed ID: 7661930
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
[TBL] [Abstract][Full Text] [Related]
29. Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.
Ponti G; Losi L; Pellacani G; Wannesson L; Cesinaro AM; Venesio T; Petti C; Seidenari S
Br J Dermatol; 2008 Jul; 159(1):162-8. PubMed ID: 18460031
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
31. Colorectal adenomatous polyposis Associated with MYH mutations: genotype and phenotype characteristics.
Bouguen G; Manfredi S; Blayau M; Dugast C; Buecher B; Bonneau D; Siproudhis L; David V; Bretagne JF
Dis Colon Rectum; 2007 Oct; 50(10):1612-7. PubMed ID: 17674103
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
33. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
[TBL] [Abstract][Full Text] [Related]
34. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909
[TBL] [Abstract][Full Text] [Related]
35. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP).
Nielsen M; Franken PF; Reinards TH; Weiss MM; Wagner A; van der Klift H; Kloosterman S; Houwing-Duistermaat JJ; Aalfs CM; Ausems MG; Bröcker-Vriends AH; Gomez Garcia EB; Hoogerbrugge N; Menko FH; Sijmons RH; Verhoef S; Kuipers EJ; Morreau H; Breuning MH; Tops CM; Wijnen JT; Vasen HF; Fodde R; Hes FJ
J Med Genet; 2005 Sep; 42(9):e54. PubMed ID: 16140997
[TBL] [Abstract][Full Text] [Related]
36. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma.
Durno C; Aronson M; Bapat B; Cohen Z; Gallinger S
Gut; 2005 Aug; 54(8):1146-50. PubMed ID: 15845562
[TBL] [Abstract][Full Text] [Related]
37. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma.
Ericson KM; Isinger AP; Isfoss BL; Nilbert MC
BMC Cancer; 2005 Mar; 5():23. PubMed ID: 15740628
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
Castells A; Payá A; Alenda C; Rodríguez-Moranta F; Agrelo R; Andreu M; Piñol V; Castellví-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Saló J; Medina E; Naranjo A; Esteller M; Piqué JM;
Clin Cancer Res; 2006 Mar; 12(6):1686-92. PubMed ID: 16551850
[TBL] [Abstract][Full Text] [Related]
39. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
40. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
